These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1111 related articles for article (PubMed ID: 24484236)

  • 1. Presence of B cells in tertiary lymphoid structures is associated with a protective immunity in patients with lung cancer.
    Germain C; Gnjatic S; Tamzalit F; Knockaert S; Remark R; Goc J; Lepelley A; Becht E; Katsahian S; Bizouard G; Validire P; Damotte D; Alifano M; Magdeleinat P; Cremer I; Teillaud JL; Fridman WH; Sautès-Fridman C; Dieu-Nosjean MC
    Am J Respir Crit Care Med; 2014 Apr; 189(7):832-44. PubMed ID: 24484236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term survival for patients with non-small-cell lung cancer with intratumoral lymphoid structures.
    Dieu-Nosjean MC; Antoine M; Danel C; Heudes D; Wislez M; Poulot V; Rabbe N; Laurans L; Tartour E; de Chaisemartin L; Lebecque S; Fridman WH; Cadranel J
    J Clin Oncol; 2008 Sep; 26(27):4410-7. PubMed ID: 18802153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring the impact of tertiary lymphoid structures maturity in NSCLC: insights from TLS scoring.
    Berthe J; Poudel P; Segerer FJ; Jennings EC; Ng F; Surace M; Andoni A; Testori M; Saraiya M; Vuko M; Hessel H; Heininen-Brown M; Blando J; Jones EV; Willis SE; Galon J; van de Ven R; de Gruijl TD; Angell HK
    Front Immunol; 2024; 15():1422206. PubMed ID: 39376565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Density of tertiary lymphoid structures and their correlation with prognosis in non-small cell lung cancer.
    Xin S; Wen S; He P; Zhao Y; Zhao H
    Front Immunol; 2024; 15():1423775. PubMed ID: 39192984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic markers in resectable non-small cell lung cancer: a multivariate analysis.
    Pelletier MP; Edwardes MD; Michel RP; Halwani F; Morin JE
    Can J Surg; 2001 Jun; 44(3):180-8. PubMed ID: 11407827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tertiary lymphoid structures, drivers of the anti-tumor responses in human cancers.
    Dieu-Nosjean MC; Giraldo NA; Kaplon H; Germain C; Fridman WH; Sautès-Fridman C
    Immunol Rev; 2016 May; 271(1):260-75. PubMed ID: 27088920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tertiary Lymphoid Structure-B Cells Narrow Regulatory T Cells Impact in Lung Cancer Patients.
    Germain C; Devi-Marulkar P; Knockaert S; Biton J; Kaplon H; Letaïef L; Goc J; Seguin-Givelet A; Gossot D; Girard N; Validire P; Lefèvre M; Damotte D; Alifano M; Lemoine FM; Steele KE; Teillaud JL; Hammond SA; Dieu-Nosjean MC
    Front Immunol; 2021; 12():626776. PubMed ID: 33763071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dendritic cells in tumor-associated tertiary lymphoid structures signal a Th1 cytotoxic immune contexture and license the positive prognostic value of infiltrating CD8+ T cells.
    Goc J; Germain C; Vo-Bourgais TK; Lupo A; Klein C; Knockaert S; de Chaisemartin L; Ouakrim H; Becht E; Alifano M; Validire P; Remark R; Hammond SA; Cremer I; Damotte D; Fridman WH; Sautès-Fridman C; Dieu-Nosjean MC
    Cancer Res; 2014 Feb; 74(3):705-15. PubMed ID: 24366885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD1c+ and CD303+ dendritic cells in peripheral blood, lymph nodes and tumor tissue of patients with non-small cell lung cancer.
    Tabarkiewicz J; Rybojad P; Jablonka A; Rolinski J
    Oncol Rep; 2008 Jan; 19(1):237-43. PubMed ID: 18097601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor microenvironment is multifaceted.
    Sautès-Fridman C; Cherfils-Vicini J; Damotte D; Fisson S; Fridman WH; Cremer I; Dieu-Nosjean MC
    Cancer Metastasis Rev; 2011 Mar; 30(1):13-25. PubMed ID: 21271351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic effect of epithelial and stromal lymphocyte infiltration in non-small cell lung cancer.
    Al-Shibli KI; Donnem T; Al-Saad S; Persson M; Bremnes RM; Busund LT
    Clin Cancer Res; 2008 Aug; 14(16):5220-7. PubMed ID: 18698040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Germinal center reactions in tertiary lymphoid structures associate with neoantigen burden, humoral immunity and long-term survivorship in pancreatic cancer.
    J Gunderson A; Rajamanickam V; Bui C; Bernard B; Pucilowska J; Ballesteros-Merino C; Schmidt M; McCarty K; Philips M; Piening B; Dubay C; Medler T; Newell P; Hansen P; Tran E; Tang E; Bifulco C; Crittenden M; Gough M; Young KH
    Oncoimmunology; 2021 Mar; 10(1):1900635. PubMed ID: 33796412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Germinal Centers Determine the Prognostic Relevance of Tertiary Lymphoid Structures and Are Impaired by Corticosteroids in Lung Squamous Cell Carcinoma.
    Siliņa K; Soltermann A; Attar FM; Casanova R; Uckeley ZM; Thut H; Wandres M; Isajevs S; Cheng P; Curioni-Fontecedro A; Foukas P; Levesque MP; Moch H; Linē A; van den Broek M
    Cancer Res; 2018 Mar; 78(5):1308-1320. PubMed ID: 29279354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A trial of autologous ex vivo-expanded NK cell-enriched lymphocytes with docetaxel in patients with advanced non-small cell lung cancer as second- or third-line treatment: phase IIa study.
    Yang YJ; Park JC; Kim HK; Kang JH; Park SY
    Anticancer Res; 2013 May; 33(5):2115-22. PubMed ID: 23645763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic and clinicopathological significance of tertiary lymphoid structure in non-small cell lung cancer: a systematic review and meta-analysis.
    Ma L; Li R; Liu X; Yu W; Tang Z; Shen Y; Tian H
    BMC Cancer; 2024 Jul; 24(1):815. PubMed ID: 38977962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prognostic relevance of tumour-infiltrating plasma cells and immunoglobulin kappa C indicates an important role of the humoral immune response in non-small cell lung cancer.
    Lohr M; Edlund K; Botling J; Hammad S; Hellwig B; Othman A; Berglund A; Lambe M; Holmberg L; Ekman S; Bergqvist M; Pontén F; Cadenas C; Marchan R; Hengstler JG; Rahnenführer J; Micke P
    Cancer Lett; 2013 Jun; 333(2):222-8. PubMed ID: 23370224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tertiary lymphoid structures in cancer and beyond.
    Dieu-Nosjean MC; Goc J; Giraldo NA; Sautès-Fridman C; Fridman WH
    Trends Immunol; 2014 Nov; 35(11):571-80. PubMed ID: 25443495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predominant infiltration of macrophages and CD8(+) T Cells in cancer nests is a significant predictor of survival in stage IV nonsmall cell lung cancer.
    Kawai O; Ishii G; Kubota K; Murata Y; Naito Y; Mizuno T; Aokage K; Saijo N; Nishiwaki Y; Gemma A; Kudoh S; Ochiai A
    Cancer; 2008 Sep; 113(6):1387-95. PubMed ID: 18671239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor-associated neutrophils and macrophages in non-small cell lung cancer: no immediate impact on patient outcome.
    Carus A; Ladekarl M; Hager H; Pilegaard H; Nielsen PS; Donskov F
    Lung Cancer; 2013 Jul; 81(1):130-7. PubMed ID: 23540719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autologous dendritic cell vaccines for non-small-cell lung cancer.
    Hirschowitz EA; Foody T; Kryscio R; Dickson L; Sturgill J; Yannelli J
    J Clin Oncol; 2004 Jul; 22(14):2808-15. PubMed ID: 15254048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 56.